Spaulding 1Source^™ Case Study

A first-in-human Phase I therapy needed to complete an interim analysis. The analysis was unplanned, and the results were set to include additional participants above and beyond the original study. What’s more, the client needed it all done according to the same fixed timeline, which made finding efficiencies absolutely necessary.

What made it all possible? Real-time data extraction and downstream data systems from Spaulding 1Source™. This case study shows how Spaulding’s proprietary system enabled a sponsor to meet a critical milestone by removing the need for transcription and evaluating data sets as they evolve.